Compare $ANGO vs $CARL | Chartloom

Compare

$ANGO vs $CARL

AngioDynamics Inc · Carlsmed Inc

ANGO

AngioDynamics Inc

CARL

Carlsmed Inc

Compare $ANGO vs $CARL

Comparing AngioDynamics Inc and Carlsmed Inc

ANGOAngioDynamics Inc

CARLCarlsmed Inc

ANGOAngioDynamics Inc

Market cap

$476M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

8.2%

YTD performance

-9.1%

52W performance

3.6%

FCF yield

-0.3%

CARLCarlsmed Inc

Market cap

$392M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.18x

Rev growth (TTM)

16.1%

YTD performance

24.0%

52W performance

4.3%

FCF yield

-9.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANGO

CARL

Detailed metrics comparison

ANGO

AngioDynamics Inc

CARL

Carlsmed Inc

Market Cap

ANGO$476M

CARL$392M

Enterprise Value

ANGO$442M

CARL$361M

Price

ANGO$11.52

CARL$14.42

P/E Ratio

ANGON/A

CARLN/A

P/S Ratio

ANGO1.46x

CARL6.19x

EV/Sales

ANGO1.36x

CARL5.70x

EV/EBITDA

ANGO631.64x

CARL0.00x

P/B Ratio

ANGO3.72x

CARL4.62x

P/FCF Ratio

ANGON/A

CARLN/A

EV/FCF

ANGO-333.70x

CARL-10.12x

PEG Ratio

ANGON/A

CARLN/A

Forward P/E (NTM)

ANGON/A

CARLN/A

Forward P/S (NTM)

ANGON/A

CARL4.18x

Revenue (TTM)

ANGO$325M

CARL$63M

Revenue Growth (YoY)

ANGO8.2%

CARL16.1%

Forward Rev Growth

ANGO5.3%

CARL40.9%

Gross Margin (TTM)

ANGO55.7%

CARL76.6%

Operating Margin (TTM)

ANGO0.0%

CARL0.0%

EBITDA Margin (TTM)

ANGO0.2%

CARL-60.4%

Net Margin (TTM)

ANGO-10.1%

CARL-57.4%

FCF Margin (TTM)

ANGO-0.4%

CARL-56.4%

Net Income (TTM)

ANGO$-33M

CARL$-36M

FCF (TTM)

ANGO$-1M

CARL$-36M

EPS (TTM)

ANGO-$0.79

CARL-$1.34

ROE (TTM)

ANGO-2101.0%

CARL-3806.0%

ROA (TTM)

ANGO-1382.0%

CARL-2896.0%

ROIC (TTM)

ANGO-2032.0%

CARL-3278.0%

Cash

ANGO$34M

CARL$46M

Debt

ANGO$0

CARL$15M

Net Cash/Debt

ANGO$34M

CARL$31M

Current Ratio (TTM)

ANGO2.19x

CARL8.84x

Quick Ratio (TTM)

ANGO1.37x

CARL8.32x

Debt/Equity (TTM)

ANGO0.03x

CARL0.18x

Debt/Assets (TTM)

ANGO0.0%

CARL0.0%

Interest Coverage (TTM)

ANGON/A

CARLN/A

Net Debt/EBITDA (TTM)

ANGO0.00x

CARL0.00x

Beta

ANGO0.23

CARL2.13

52W Performance

ANGO3.6%

CARL4.3%

YTD Performance

ANGO-9.1%

CARL24.0%

% from 52W High

ANGO-29.3%

CARL-16.3%

% from 52W Low

ANGO22.7%

CARL69.6%

Asset Turnover (TTM)

ANGO1.20x

CARL0.50x

FCF Yield (TTM)

ANGO-0.3%

CARL-9.1%

Earnings Yield (TTM)

ANGO-6.9%

CARL-9.3%

Dividend Yield (TTM)

ANGON/A

CARLN/A

Rule of 40

ANGO7.8

CARL-40.3

EV/GP/RG

ANGO0.46

CARL0.14

Ticker research

View ANGO research View CARL research

Metric	ANGO AngioDynamics Inc	CARL Carlsmed Inc
Market & Valuation
Market Cap	$476M	$392M
Enterprise Value	$442M	$361M
Price	$11.52	$14.42
P/E Ratio	N/A	N/A
P/S Ratio	1.46x	6.19x
EV/Sales	1.36x	5.70x
EV/EBITDA	631.64x	0.00x
P/B Ratio	3.72x	4.62x
P/FCF Ratio	N/A	N/A
EV/FCF	-333.70x	-10.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	4.18x
Revenue & Growth
Revenue (TTM)	$325M	$63M
Revenue Growth (YoY)	8.2%	16.1%
Forward Rev Growth	5.3%	40.9%
Profitability
Gross Margin (TTM)	55.7%	76.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.2%	-60.4%
Net Margin (TTM)	-10.1%	-57.4%
FCF Margin (TTM)	-0.4%	-56.4%
Net Income (TTM)	$-33M	$-36M
FCF (TTM)	$-1M	$-36M
EPS (TTM)	-$0.79	-$1.34
ROE (TTM)	-2101.0%	-3806.0%
ROA (TTM)	-1382.0%	-2896.0%
ROIC (TTM)	-2032.0%	-3278.0%
Financial Health
Cash	$34M	$46M
Debt	$0	$15M
Net Cash/Debt	$34M	$31M
Current Ratio (TTM)	2.19x	8.84x
Quick Ratio (TTM)	1.37x	8.32x
Debt/Equity (TTM)	0.03x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	2.13
52W Performance	3.6%	4.3%
YTD Performance	-9.1%	24.0%
% from 52W High	-29.3%	-16.3%
% from 52W Low	22.7%	69.6%
Efficiency & Yields
Asset Turnover (TTM)	1.20x	0.50x
FCF Yield (TTM)	-0.3%	-9.1%
Earnings Yield (TTM)	-6.9%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	7.8	-40.3
EV/GP/RG	0.46	0.14
Ticker research	View ANGO research	View CARL research

Valuation

P/S Ratio

ANGO

1.46x

CARL

6.19x

EV/FCF

ANGO

-333.70x

CARL

-10.12x

Growth & revenue

Revenue Growth TTM

CARL

16.1%

ANGO

8.2%

Forward Revenue Growth

CARL

40.9%

ANGO

5.3%

Profitability & performance

Gross Margin

CARL

76.6%

ANGO

55.7%

ROE

ANGO

-2101.0%

CARL

-3806.0%

FCF Yield %

ANGO

-0.3%

CARL

-9.1%

52-Week Performance

CARL

4.3%

ANGO

3.6%

Detailed metrics comparison

ANGO

AngioDynamics Inc

CARL

Carlsmed Inc

Market Cap

ANGO$476M

CARL$392M

Enterprise Value

ANGO$442M

CARL$361M

Price

ANGO$11.52

CARL$14.42

P/E Ratio

ANGON/A

CARLN/A

P/S Ratio

ANGO1.46x

CARL6.19x

EV/Sales

ANGO1.36x

CARL5.70x

EV/EBITDA

ANGO631.64x

CARL0.00x

P/B Ratio

ANGO3.72x

CARL4.62x

P/FCF Ratio

ANGON/A

CARLN/A

EV/FCF

ANGO-333.70x

CARL-10.12x

PEG Ratio

ANGON/A

CARLN/A

Forward P/E (NTM)

ANGON/A

CARLN/A

Forward P/S (NTM)

ANGON/A

CARL4.18x

Revenue (TTM)

ANGO$325M

CARL$63M

Revenue Growth (YoY)

ANGO8.2%

CARL16.1%

Forward Rev Growth

ANGO5.3%

CARL40.9%

Gross Margin (TTM)

ANGO55.7%

CARL76.6%

Operating Margin (TTM)

ANGO0.0%

CARL0.0%

EBITDA Margin (TTM)

ANGO0.2%

CARL-60.4%

Net Margin (TTM)

ANGO-10.1%

CARL-57.4%

FCF Margin (TTM)

ANGO-0.4%

CARL-56.4%

Net Income (TTM)

ANGO$-33M

CARL$-36M

FCF (TTM)

ANGO$-1M

CARL$-36M

EPS (TTM)

ANGO-$0.79

CARL-$1.34

ROE (TTM)

ANGO-2101.0%

CARL-3806.0%

ROA (TTM)

ANGO-1382.0%

CARL-2896.0%

ROIC (TTM)

ANGO-2032.0%

CARL-3278.0%

Cash

ANGO$34M

CARL$46M

Debt

ANGO$0

CARL$15M

Net Cash/Debt

ANGO$34M

CARL$31M

Current Ratio (TTM)

ANGO2.19x

CARL8.84x

Quick Ratio (TTM)

ANGO1.37x

CARL8.32x

Debt/Equity (TTM)

ANGO0.03x

CARL0.18x

Debt/Assets (TTM)

ANGO0.0%

CARL0.0%

Interest Coverage (TTM)

ANGON/A

CARLN/A

Net Debt/EBITDA (TTM)

ANGO0.00x

CARL0.00x

Beta

ANGO0.23

CARL2.13

52W Performance

ANGO3.6%

CARL4.3%

YTD Performance

ANGO-9.1%

CARL24.0%

% from 52W High

ANGO-29.3%

CARL-16.3%

% from 52W Low

ANGO22.7%

CARL69.6%

Asset Turnover (TTM)

ANGO1.20x

CARL0.50x

FCF Yield (TTM)

ANGO-0.3%

CARL-9.1%

Earnings Yield (TTM)

ANGO-6.9%

CARL-9.3%

Dividend Yield (TTM)

ANGON/A

CARLN/A

Rule of 40

ANGO7.8

CARL-40.3

EV/GP/RG

ANGO0.46

CARL0.14

Ticker research

View ANGO research View CARL research

Metric	ANGO AngioDynamics Inc	CARL Carlsmed Inc
Market & Valuation
Market Cap	$476M	$392M
Enterprise Value	$442M	$361M
Price	$11.52	$14.42
P/E Ratio	N/A	N/A
P/S Ratio	1.46x	6.19x
EV/Sales	1.36x	5.70x
EV/EBITDA	631.64x	0.00x
P/B Ratio	3.72x	4.62x
P/FCF Ratio	N/A	N/A
EV/FCF	-333.70x	-10.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	4.18x
Revenue & Growth
Revenue (TTM)	$325M	$63M
Revenue Growth (YoY)	8.2%	16.1%
Forward Rev Growth	5.3%	40.9%
Profitability
Gross Margin (TTM)	55.7%	76.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.2%	-60.4%
Net Margin (TTM)	-10.1%	-57.4%
FCF Margin (TTM)	-0.4%	-56.4%
Net Income (TTM)	$-33M	$-36M
FCF (TTM)	$-1M	$-36M
EPS (TTM)	-$0.79	-$1.34
ROE (TTM)	-2101.0%	-3806.0%
ROA (TTM)	-1382.0%	-2896.0%
ROIC (TTM)	-2032.0%	-3278.0%
Financial Health
Cash	$34M	$46M
Debt	$0	$15M
Net Cash/Debt	$34M	$31M
Current Ratio (TTM)	2.19x	8.84x
Quick Ratio (TTM)	1.37x	8.32x
Debt/Equity (TTM)	0.03x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	2.13
52W Performance	3.6%	4.3%
YTD Performance	-9.1%	24.0%
% from 52W High	-29.3%	-16.3%
% from 52W Low	22.7%	69.6%
Efficiency & Yields
Asset Turnover (TTM)	1.20x	0.50x
FCF Yield (TTM)	-0.3%	-9.1%
Earnings Yield (TTM)	-6.9%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	7.8	-40.3
EV/GP/RG	0.46	0.14
Ticker research	View ANGO research	View CARL research